Home › Lab21 And IntegraGen Partner To Develop New Colorectal Cancer Diagnostic
 

Keywords :   


Lab21 And IntegraGen Partner To Develop New Colorectal Cancer Diagnostic

2013-02-22 06:09:00| drugdiscoveryonline News Articles

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes

Tags: partner develop cancer diagnostic

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.09Tropical Storm Helene Forecast Discussion Number 6
24.09Tropical Storm Helene Wind Speed Probabilities Number 6
24.09Tropical Storm Helene Public Advisory Number 6
24.09Summary for Tropical Storm Helene (AT4/AL092024)
24.09Tropical Storm Helene Forecast Advisory Number 6
24.09US accuses Visa of debit card monopoly
24.09China probes Calvin Klein over Xinjiang cotton
24.09EPA Names ACI as 2024 Safer Choice Partner of the Year
More »